Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Supernus Pharmaceuticals Inc (NASDAQ: SUPN) closed the day trading at $31.11 up 0.68% from the previous closing price of $30.90. In other words, the price has increased by $0.68 from its previous closing price. On the day, 0.59 million shares were traded. SUPN stock price reached its highest trading level at $31.62 during the session, while it also had its lowest trading level at $30.985.
Ratios:
For a better understanding of SUPN, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.94 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 11.10. For the most recent quarter (mrq), Quick Ratio is recorded 1.69 and its Current Ratio is at 1.91. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Piper Sandler on September 11, 2024, Downgraded its rating to Neutral and sets its target price to $36 from $41 previously.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 13 ’24 when GEORGES GEMAYEL bought 13,886 shares for $31.33 per share.
TAMI TILLOTSON MARTIN bought 4,000 shares of SUPN for $116,074 on Aug 02 ’24. On Aug 01 ’24, another insider, TAMI TILLOTSON MARTIN, who serves as the Former Officer of the company, bought 3,100 shares for $29.31 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SUPN now has a Market Capitalization of 1714329088 and an Enterprise Value of 1407118592. As of this moment, Supernus’s Price-to-Earnings (P/E) ratio for their current fiscal year is 352.32, and their Forward P/E ratio for the next fiscal year is 17.06. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 208.47. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.72 while its Price-to-Book (P/B) ratio in mrq is 1.79. Its current Enterprise Value per Revenue stands at 2.233 whereas that against EBITDA is 11.2.
Stock Price History:
Over the past 52 weeks, SUPN has reached a high of $35.44, while it has fallen to a 52-week low of $21.99. The 50-Day Moving Average of the stock is -0.95%, while the 200-Day Moving Average is calculated to be 4.90%.
Shares Statistics:
Over the past 3-months, SUPN traded about 532.21K shares per day on average, while over the past 10 days, SUPN traded about 421310 shares per day. A total of 54.72M shares are outstanding, with a floating share count of 52.76M. Insiders hold about 4.26% of the company’s shares, while institutions hold 107.75% stake in the company. Shares short for SUPN as of 1724976000 were 6667905 with a Short Ratio of 12.53, compared to 1722384000 on 6161942. Therefore, it implies a Short% of Shares Outstanding of 6667905 and a Short% of Float of 18.43.
